(1)
Restelli, U.; Alberti, A.; Lazzarin, A.; Bonfanti, M.; Nappi, C.; Croce, D. Budget Impact Analysis of the Use of Daclatasvir in Italy for the Treatment of Hepatitis C Virus (HCV) Genotype 3 Patients. FE 2016, 17, 7-12.